skip to main content

Cardiovascular risk reduction — MCCQE Part 1 MCQ

Instant feedback + full explanation. One question, done properly.

ModeratePreventive MedicineCardiovascular risk reductionMCCQE Part 1

A 50-year-old man with family history of premature CAD (father MI at 45) has LDL 3.8 mmol/L. Non-smoker, no DM, BP 130/80. FRS 15% (intermediate risk). Most appropriate management?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EStatin therapy

CCS Dyslipidemia: intermediate risk (FRS 10-19%) with LDL >3.5 or family history of premature CAD warrants statin. CCS 2021: ASA NOT recommended for primary prevention. Ezetimibe add-on if LDL target not met.

Reference: CCS Dyslipidemia 2021